Clinical investigation of Optos ORG v1.0

  • Research type

    Research Study

  • Full title

    Clinical investigation of Optos ORG in patients with retinal pathologies

  • IRAS ID

    338297

  • Contact name

    Mark Hope

  • Contact email

    mhope@optos.com

  • Sponsor organisation

    Optos Plc

  • Clinicaltrials.gov Identifier

    NCT06846151

  • Duration of Study in the UK

    0 years, 6 months, 28 days

  • Research summary

    Optoretinography (ORG) is the recording of physiological change within the retina (back of the eye) caused by a flashing light. It makes use of optical coherence tomography (OCT) technology and enhanced post processing methods to determine the retina response to a bright flash of visible light. ORG has the potential to detect loss of function within the retina due to disease, providing clinicians with enhanced diagnostic tools enabling earlier diagnosis, quantifiable measures of disease progression and enhanced disease understanding.

    The Primary objective of this study is to collect ORG data on a control group and retinas with predefined disease types to aid in the evaluation and development of a new prototype device.

  • REC name

    North of Scotland Research Ethics Committee 1

  • REC reference

    25/NS/0018

  • Date of REC Opinion

    21 Mar 2025

  • REC opinion

    Further Information Favourable Opinion